Logo image of ACR

ACRES COMMERCIAL REALTY CORP (ACR) Stock Fundamental Analysis

USA - NYSE:ACR - US00489Q1022 - REIT

19.28 USD
-0.03 (-0.16%)
Last: 10/22/2025, 7:15:42 PM
19.28 USD
0 (0%)
After Hours: 10/22/2025, 7:15:42 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ACR. ACR was compared to 66 industry peers in the Mortgage Real Estate Investment Trusts (REITs)" industry. While ACR is still in line with the averages on profitability rating, there are concerns on its financial health. ACR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year ACR has reported negative net income.
In the past year ACR had a positive cash flow from operations.
In multiple years ACR reported negative net income over the last 5 years.
In the past 5 years ACR always reported a positive cash flow from operatings.
ACR Yearly Net Income VS EBIT VS OCF VS FCFACR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

1.2 Ratios

With a Return On Assets value of 0.02%, ACR is not doing good in the industry: 62.12% of the companies in the same industry are doing better.
ACR has a Return On Equity of 0.08%. This is in the lower half of the industry: ACR underperforms 62.12% of its industry peers.
ACR has a Return On Invested Capital of 0.57%. This is in the better half of the industry: ACR outperforms 68.18% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ACR is in line with the industry average of 1.28%.
The 3 year average ROIC (0.53%) for ACR is below the current ROIC(0.57%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.02%
ROE 0.08%
ROIC 0.57%
ROA(3y)0.08%
ROA(5y)-2.31%
ROE(3y)0.25%
ROE(5y)-11.49%
ROIC(3y)0.53%
ROIC(5y)N/A
ACR Yearly ROA, ROE, ROICACR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

The Profit Margin of ACR (0.18%) is worse than 62.12% of its industry peers.
In the last couple of years the Profit Margin of ACR has declined.
ACR has a Operating Margin (6.47%) which is comparable to the rest of the industry.
ACR's Operating Margin has declined in the last couple of years.
ACR has a better Gross Margin (42.19%) than 83.33% of its industry peers.
ACR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.47%
PM (TTM) 0.18%
GM 42.19%
OM growth 3Y-46.25%
OM growth 5Y-26.58%
PM growth 3Y-34.18%
PM growth 5Y-23.68%
GM growth 3Y-1.09%
GM growth 5Y1.39%
ACR Yearly Profit, Operating, Gross MarginsACR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ACR is destroying value.
The number of shares outstanding for ACR has been reduced compared to 1 year ago.
Compared to 5 years ago, ACR has less shares outstanding
The debt/assets ratio for ACR has been reduced compared to a year ago.
ACR Yearly Shares OutstandingACR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ACR Yearly Total Debt VS Total AssetsACR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

Based on the Altman-Z score of -0.47, we must say that ACR is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ACR (-0.47) is worse than 62.12% of its industry peers.
ACR has a Debt/Equity ratio of 2.78. This is a high value indicating a heavy dependency on external financing.
ACR has a Debt to Equity ratio of 2.78. This is in the better half of the industry: ACR outperforms 74.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.78
Debt/FCF N/A
Altman-Z -0.47
ROIC/WACC0.08
WACC6.83%
ACR Yearly LT Debt VS Equity VS FCFACR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 0.31 indicates that ACR may have some problems paying its short term obligations.
The Current ratio of ACR (0.31) is better than 60.61% of its industry peers.
A Quick Ratio of 0.31 indicates that ACR may have some problems paying its short term obligations.
ACR's Quick ratio of 0.31 is fine compared to the rest of the industry. ACR outperforms 60.61% of its industry peers.
Industry RankSector Rank
Current Ratio 0.31
Quick Ratio 0.31
ACR Yearly Current Assets VS Current LiabilitesACR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2

3. Growth

3.1 Past

The earnings per share for ACR have decreased strongly by -105.13% in the last year.
ACR shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -15.41% yearly.
The Revenue for ACR has decreased by -15.89% in the past year. This is quite bad
ACR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.60% yearly.
EPS 1Y (TTM)-105.13%
EPS 3Y-14.58%
EPS 5Y-15.41%
EPS Q2Q%-92.16%
Revenue 1Y (TTM)-15.89%
Revenue growth 3Y21.05%
Revenue growth 5Y6.6%
Sales Q2Q%4.48%

3.2 Future

Based on estimates for the next years, ACR will show a very negative growth in Earnings Per Share. The EPS will decrease by -11.21% on average per year.
Based on estimates for the next years, ACR will show a small growth in Revenue. The Revenue will grow by 1.26% on average per year.
EPS Next Y-137.78%
EPS Next 2Y-11.21%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-0.69%
Revenue Next 2Y1.26%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ACR Yearly Revenue VS EstimatesACR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 100M 200M
ACR Yearly EPS VS EstimatesACR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 4 -4

1

4. Valuation

4.1 Price/Earnings Ratio

ACR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 17.59, ACR is valued on the expensive side.
Based on the Price/Forward Earnings ratio, ACR is valued a bit more expensive than the industry average as 66.67% of the companies are valued more cheaply.
The average S&P500 Price/Forward Earnings ratio is at 23.09. ACR is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 17.59
ACR Price Earnings VS Forward Price EarningsACR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150

4.2 Price Multiples

ACR's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ACR is cheaper than 84.85% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 56.14
ACR Per share dataACR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

A cheap valuation may be justified as ACR's earnings are expected to decrease with -11.21% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-11.21%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ACR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ACRES COMMERCIAL REALTY CORP

NYSE:ACR (10/22/2025, 7:15:42 PM)

After market: 19.28 0 (0%)

19.28

-0.03 (-0.16%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryMortgage Real Estate Investment Trusts (REITs)"
Earnings (Last)07-30 2025-07-30/amc
Earnings (Next)10-29 2025-10-29/amc
Inst Owners51.16%
Inst Owner Change0.01%
Ins Owners3.46%
Ins Owner Change-0.12%
Market Cap143.25M
Revenue(TTM)180.58M
Net Income(TTM)323.00K
Analysts76.67
Price Target23.97 (24.33%)
Short Float %3.03%
Short Ratio8.69
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend2.58
Dividend Growth(5Y)-6.04%
DP6513.31%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-169.78%
Min EPS beat(2)-262.19%
Max EPS beat(2)-77.37%
EPS beat(4)1
Avg EPS beat(4)-74.95%
Min EPS beat(4)-262.19%
Max EPS beat(4)79.34%
EPS beat(8)4
Avg EPS beat(8)-35.48%
EPS beat(12)8
Avg EPS beat(12)-15.84%
EPS beat(16)10
Avg EPS beat(16)-25.89%
Revenue beat(2)1
Avg Revenue beat(2)-8.17%
Min Revenue beat(2)-22.92%
Max Revenue beat(2)6.58%
Revenue beat(4)2
Avg Revenue beat(4)-3.69%
Min Revenue beat(4)-22.92%
Max Revenue beat(4)6.58%
Revenue beat(8)4
Avg Revenue beat(8)0.67%
Revenue beat(12)8
Avg Revenue beat(12)30.82%
Revenue beat(16)12
Avg Revenue beat(16)55.98%
PT rev (1m)0%
PT rev (3m)6.82%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-53.33%
EPS NY rev (1m)-159.43%
EPS NY rev (3m)-200%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)9.67%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.34%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 17.59
P/S 0.79
P/FCF N/A
P/OCF 8.64
P/B 0.34
P/tB 0.34
EV/EBITDA 56.14
EPS(TTM)-0.1
EYN/A
EPS(NY)1.1
Fwd EY5.68%
FCF(TTM)-0.61
FCFYN/A
OCF(TTM)2.23
OCFY11.58%
SpS24.3
BVpS57.24
TBVpS56.34
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 0.02%
ROE 0.08%
ROCE 0.72%
ROIC 0.57%
ROICexc 0.58%
ROICexgc 0.59%
OM 6.47%
PM (TTM) 0.18%
GM 42.19%
FCFM N/A
ROA(3y)0.08%
ROA(5y)-2.31%
ROE(3y)0.25%
ROE(5y)-11.49%
ROIC(3y)0.53%
ROIC(5y)N/A
ROICexc(3y)0.55%
ROICexc(5y)N/A
ROICexgc(3y)0.55%
ROICexgc(5y)N/A
ROCE(3y)0.67%
ROCE(5y)N/A
ROICexgc growth 3Y-27.63%
ROICexgc growth 5Y-15.6%
ROICexc growth 3Y-27.72%
ROICexc growth 5Y-15.71%
OM growth 3Y-46.25%
OM growth 5Y-26.58%
PM growth 3Y-34.18%
PM growth 5Y-23.68%
GM growth 3Y-1.09%
GM growth 5Y1.39%
F-Score6
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 2.78
Debt/FCF N/A
Debt/EBITDA 47.07
Cap/Depr 157%
Cap/Sales 11.68%
Interest Coverage 0.12
Cash Conversion 66.05%
Profit Quality N/A
Current Ratio 0.31
Quick Ratio 0.31
Altman-Z -0.47
F-Score6
WACC6.83%
ROIC/WACC0.08
Cap/Depr(3y)766.24%
Cap/Depr(5y)459.83%
Cap/Sales(3y)30.67%
Cap/Sales(5y)18.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-105.13%
EPS 3Y-14.58%
EPS 5Y-15.41%
EPS Q2Q%-92.16%
EPS Next Y-137.78%
EPS Next 2Y-11.21%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-15.89%
Revenue growth 3Y21.05%
Revenue growth 5Y6.6%
Sales Q2Q%4.48%
Revenue Next Year-0.69%
Revenue Next 2Y1.26%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-34.43%
EBIT growth 3Y-34.93%
EBIT growth 5Y-21.74%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-125.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-61.82%
OCF growth 3Y-21.84%
OCF growth 5Y-14.85%